Publication | Closed Access
Long‐term off‐label dupilumab in pediatric atopic dermatitis: A case series
32
Citations
7
References
2018
Year
Dupilumab appears to be an effective treatment for AD in pediatric patients. Optimal dose and delivery have yet to be determined.
| Year | Citations | |
|---|---|---|
Page 1
Page 1